Veradermics (MANE) Accounts Payables (2024 - 2026)

Veradermics has reported Accounts Payables for 3 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $2.1 million, down 5.43% from the prior year.
• Accounts Payables for Q1 2026 stood at $1.1 million, down from $2.1 million in the prior quarter.
• The five-year high for Accounts Payables was $2.2 million in Q4 2024, with the low at $1.1 million in Q1 2026.
• Historically, Accounts Payables has averaged $1.8 million across 3 years, with a median of $2.1 million in 2025.
• The largest YoY upside for Accounts Payables was 5.43% in 2025 against a maximum downside of 5.43% in 2025.
• Veradermics' Accounts Payables stood at $2.2 million in 2024, then dropped by 5.43% to $2.1 million in 2025, then sank by 49.62% to $1.1 million in 2026.
• The last three Accounts Payables figures came in at $1.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.2 million (Q4 2024), per Business Quant data.